tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Survival Data and Regulatory Progress Bolster Buy Rating for Brainstorm Cell Therapeutics
PremiumRatingsPromising Survival Data and Regulatory Progress Bolster Buy Rating for Brainstorm Cell Therapeutics
1M ago
BrainStorm reports new survival data from EAP for NurOwn
Premium
The Fly
BrainStorm reports new survival data from EAP for NurOwn
1M ago
Strategic Advancements and Potential of BrainStorm Cell Therapeutics: A Buy Recommendation by Jason McCarthy
Premium
Ratings
Strategic Advancements and Potential of BrainStorm Cell Therapeutics: A Buy Recommendation by Jason McCarthy
2M ago
Brainstorm Cell Therapeutics Reports Q1 2025 Financials
PremiumCompany AnnouncementsBrainstorm Cell Therapeutics Reports Q1 2025 Financials
2M ago
Brainstorm Cell Therapeutics: Progress and Challenges in ALS Trial
Premium
Company Announcements
Brainstorm Cell Therapeutics: Progress and Challenges in ALS Trial
2M ago
One new option listing and nine option delistings on May 19th
Premium
The Fly
One new option listing and nine option delistings on May 19th
2M ago
BCLI Earnings this Week: How Will it Perform?
PremiumPre-EarningsBCLI Earnings this Week: How Will it Perform?
4M ago
BrainStorm granted compliance extension from Nasdaq
Premium
The Fly
BrainStorm granted compliance extension from Nasdaq
4M ago
BrainStorm receives Notice of Allowance for patent on exosome technology
Premium
The Fly
BrainStorm receives Notice of Allowance for patent on exosome technology
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100